Found 15 hits of kd data for polymerid = 49000839,49000840,49000841,49000842,49000843 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003049
(CHEMBL3559527 | Tyr-Pro-Ser-Lys-Pro-Ala-Asn-Pro-Gl...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)N(C)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C163H248N48O42/c1-15-84(7)128(152(246)200-114(75-125(167)221)141(235)194-110(68-83(5)6)143(237)205-129(85(8)16-2)153(247)206-130(89(12)214)154(248)190-104(30-21-61-181-162(174)175)134(228)189-105(56-57-124(166)220)137(231)187-102(28-19-59-179-160(170)171)135(229)193-108(131(169)225)70-91-38-48-97(216)49-39-91)204-144(238)112(72-93-42-52-99(218)53-43-93)195-140(234)113(74-95-78-178-81-183-95)196-136(230)103(29-20-60-180-161(172)173)188-138(232)109(67-82(3)4)197-148(242)120-33-23-63-208(120)155(249)88(11)186-145(239)117(79-212)202-139(233)111(71-92-40-50-98(217)51-41-92)198-150(244)122(73-94-44-54-100(219)55-45-94)207(13)156(250)106(31-22-62-182-163(176)177)191-133(227)87(10)184-132(226)86(9)185-147(241)119-32-24-65-210(119)158(252)116(76-126(168)222)201-142(236)115(77-127(223)224)199-149(243)121-34-25-64-209(121)157(251)107(27-17-18-58-164)192-146(240)118(80-213)203-151(245)123-35-26-66-211(123,14)159(253)101(165)69-90-36-46-96(215)47-37-90/h36-55,78,81-89,101-123,128-130,212-214H,15-35,56-77,79-80,164-165H2,1-14H3,(H53-,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248)/p+1/t84-,85-,86-,87-,88-,89+,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,128-,129-,130-,211?/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003055
(CHEMBL414947 | Tyr-Pro-Ser-Lys-Pro-Ala-Leu-Arg-His...)Show SMILES CCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N(C)[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C110H174N34O26/c1-11-21-73(131-90(153)60(8)127-100(163)82-26-20-47-144(82)107(170)74(22-14-15-42-111)132-98(161)80(55-145)138-101(164)83-27-19-46-143(83)105(168)69(112)49-62-28-34-66(147)35-29-62)106(169)142(10)81(25-18-45-125-110(120)121)99(162)136-78(52-65-54-122-56-126-65)94(157)135-77(51-64-32-38-68(149)39-33-64)97(160)139-86(58(6)12-2)102(165)137-79(53-85(114)151)95(158)134-76(48-57(4)5)96(159)140-87(59(7)13-3)103(166)141-88(61(9)146)104(167)130-71(24-17-44-124-109(118)119)91(154)129-72(40-41-84(113)150)93(156)128-70(23-16-43-123-108(116)117)92(155)133-75(89(115)152)50-63-30-36-67(148)37-31-63/h28-39,54,56-61,69-83,86-88,145-149H,11-27,40-53,55,111-112H2,1-10H3,(H2,113,150)(H2,114,151)(H2,115,152)(H,122,126)(H,127,163)(H,128,156)(H,129,154)(H,130,167)(H,131,153)(H,132,161)(H,133,155)(H,134,158)(H,135,157)(H,136,162)(H,137,165)(H,138,164)(H,139,160)(H,140,159)(H,141,166)(H4,116,117,123)(H4,118,119,124)(H4,120,121,125)/t58-,59-,60-,61+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,86-,87-,88-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50368404
(CHEMBL409167)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C112H174N36O27/c1-12-57(7)87(106(173)144-83(51-86(115)156)102(169)139-78(45-56(5)6)103(170)147-88(58(8)13-2)107(174)148-89(61(11)150)108(175)136-74(21-17-43-129-112(123)124)93(160)135-75(38-39-85(114)155)97(164)133-72(19-15-41-127-110(119)120)94(161)137-76(90(116)157)46-62-22-30-67(151)31-23-62)146-104(171)81(49-65-28-36-70(154)37-29-65)142-101(168)82(50-66-52-125-54-130-66)143-96(163)73(20-16-42-128-111(121)122)134-98(165)77(44-55(3)4)138-92(159)60(10)131-105(172)84(53-149)145-100(167)80(48-64-26-34-69(153)35-27-64)141-99(166)79(47-63-24-32-68(152)33-25-63)140-95(162)71(132-91(158)59(9)113)18-14-40-126-109(117)118/h22-37,52,54-61,71-84,87-89,149-154H,12-21,38-51,53,113H2,1-11H3,(H2,114,155)(H2,115,156)(H2,116,157)(H,125,130)(H,131,172)(H,132,158)(H,133,164)(H,134,165)(H,135,160)(H,136,175)(H,137,161)(H,138,159)(H,139,169)(H,140,162)(H,141,166)(H,142,168)(H,143,163)(H,144,173)(H,145,167)(H,146,171)(H,147,170)(H,148,174)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)(H4,123,124,129)/t57-,58-,59-,60-,61+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,87-,88-,89-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50437008
(CHEMBL2403028)Show SMILES CCN(CC)C(=O)C(C1CCN(CC1)c1ccc(NC(=O)Nc2c(C)noc2C)cc1F)c1ccccc1 Show InChI InChI=1S/C29H36FN5O3/c1-5-34(6-2)28(36)26(21-10-8-7-9-11-21)22-14-16-35(17-15-22)25-13-12-23(18-24(25)30)31-29(37)32-27-19(3)33-38-20(27)4/h7-13,18,22,26H,5-6,14-17H2,1-4H3,(H2,31,32,37) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a |
Janssen Research& Development LLC
Curated by ChEMBL
| Assay Description
Antagonist activity at NPY-Y2 receptor in human KAN-TS cell membranes assessed as inhibition of PYY-stimulated [35S]GTPgammaS binding preincubated fo... |
Bioorg Med Chem Lett 23: 4141-4 (2013)
Article DOI: 10.1016/j.bmcl.2013.05.038
BindingDB Entry DOI: 10.7270/Q29C6ZV8 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003048
(CHEMBL265008 | Tyr-Pro-Ser-Lys-Pro-Lys-Leu-Arg-His...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N([C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(O)=O)C(C)=O Show InChI InChI=1S/C163H250N46O44/c1-15-85(9)129(204-148(241)116(74-95-43-53-101(218)54-44-95)197-144(237)117(75-96-78-177-81-182-96)198-137(230)105(30-22-62-179-161(171)172)187-141(234)111(68-83(5)6)192-135(228)103(27-17-19-59-164)188-150(243)123-34-26-66-208(123)157(250)108(28-18-20-60-165)190-149(242)120(79-210)202-151(244)122-33-25-65-207(122)156(249)102(166)70-91-35-45-97(214)46-36-91)153(246)201-118(76-126(168)220)145(238)194-112(69-84(7)8)147(240)205-130(86(10)16-2)154(247)206-131(89(13)212)155(248)189-106(31-23-63-180-162(173)174)134(227)191-109(55-57-125(167)219)158(251)209(90(14)213)124(32-24-64-181-163(175)176)152(245)200-113(71-92-37-47-98(215)48-38-92)140(233)184-88(12)133(226)186-107(56-58-127(221)222)138(231)199-119(77-128(223)224)146(239)193-110(67-82(3)4)139(232)183-87(11)132(225)185-104(29-21-61-178-160(169)170)136(229)195-114(72-93-39-49-99(216)50-40-93)142(235)196-115(73-94-41-51-100(217)52-42-94)143(236)203-121(80-211)159(252)253/h35-54,78,81-89,102-124,129-131,210-212,214-218H,15-34,55-77,79-80,164-166H2,1-14H3,(H2,167,219)(H2,168,220)(H,177,182)(H,183,232)(H,184,233)(H,185,225)(H,186,226)(H,187,234)(H,188,243)(H,189,248)(H,190,242)(H,191,227)(H,192,228)(H,193,239)(H,194,238)(H,195,229)(H,196,235)(H,197,237)(H,198,230)(H,199,231)(H,200,245)(H,201,246)(H,202,244)(H,203,236)(H,204,241)(H,205,240)(H,206,247)(H,221,222)(H,223,224)(H,252,253)(H4,169,170,178)(H4,171,172,179)(H4,173,174,180)(H4,175,176,181)/t85-,86-,87-,88-,89+,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,129-,130-,131-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003051
(CHEMBL385339 | c(2,27)Tyr-Glu-Ser-Lys-Pro-Dpr-Leu-...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@]1(C)NC(=O)CC[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N1)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C104H168N34O27/c1-12-53(7)79(96(160)134-81(56(10)140)97(161)125-65(23-18-40-118-103(113)114)84(148)124-66(33-35-76(107)143)87(151)122-64(22-17-39-117-102(111)112)86(150)131-73(99(163)164)45-58-27-31-61(142)32-28-58)133-91(155)70(43-52(5)6)128-90(154)72(47-77(108)144)130-95(159)80(54(8)13-2)135-100(165)104(11)136-78(145)36-34-67(121-83(147)62(106)44-57-25-29-60(141)30-26-57)88(152)132-74(49-139)92(156)126-68(20-14-15-37-105)98(162)138-41-19-24-75(138)94(158)120-55(9)82(146)127-69(42-51(3)4)89(153)123-63(21-16-38-116-101(109)110)85(149)129-71(93(157)137-104)46-59-48-115-50-119-59/h25-32,48,50-56,62-75,79-81,139-142H,12-24,33-47,49,105-106H2,1-11H3,(H2,107,143)(H2,108,144)(H,115,119)(H,120,158)(H,121,147)(H,122,151)(H,123,153)(H,124,148)(H,125,161)(H,126,156)(H,127,146)(H,128,154)(H,129,149)(H,130,159)(H,131,150)(H,132,152)(H,133,155)(H,134,160)(H,135,165)(H,136,145)(H,137,157)(H,163,164)(H4,109,110,116)(H4,111,112,117)(H4,113,114,118)/t53-,54-,55+,56+,62-,63+,64-,65-,66-,67-,68+,69-,70-,71-,72-,73-,74-,75-,79-,80-,81-,104-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50437009
(CHEMBL2403027)Show SMILES CCNC(=O)C(C1CCN(CC1)c1ccc(NC(=O)Nc2c(C)noc2C)cc1F)c1ccccc1 Show InChI InChI=1S/C27H32FN5O3/c1-4-29-26(34)24(19-8-6-5-7-9-19)20-12-14-33(15-13-20)23-11-10-21(16-22(23)28)30-27(35)31-25-17(2)32-36-18(25)3/h5-11,16,20,24H,4,12-15H2,1-3H3,(H,29,34)(H2,30,31,35) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a |
Janssen Research& Development LLC
Curated by ChEMBL
| Assay Description
Antagonist activity at NPY-Y2 receptor in human KAN-TS cell membranes assessed as inhibition of PYY-stimulated [35S]GTPgammaS binding preincubated fo... |
Bioorg Med Chem Lett 23: 4141-4 (2013)
Article DOI: 10.1016/j.bmcl.2013.05.038
BindingDB Entry DOI: 10.7270/Q29C6ZV8 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003053
(CHEMBL265637 | Tyr-Pro-Ser-Lys-Pro-Lys-Leu-Arg-His...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N([C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(N)=O)C(C)=O Show InChI InChI=1S/C191H291N55O55/c1-16-97(9)151(239-174(288)130(82-107-46-56-113(254)57-47-107)231-170(284)131(84-109-89-207-93-213-109)232-160(274)118(33-23-69-209-189(201)202)221-167(281)126(77-95(5)6)226-158(272)116(30-18-20-66-192)223-178(292)141-39-29-74-244(141)185(299)124(31-19-21-67-193)225-175(289)137(92-248)238-179(293)140-38-28-73-243(140)184(298)115(194)79-104-40-50-110(251)51-41-104)180(294)235-132(85-144(196)257)171(285)228-127(78-96(7)8)173(287)240-152(98(10)17-2)181(295)241-153(102(14)249)182(296)224-120(35-25-71-211-191(205)206)157(271)222-122(60-63-143(195)256)163(277)220-119(34-24-70-210-190(203)204)161(275)236-135(83-108-48-58-114(255)59-49-108)186(300)246(103(15)250)142(88-145(197)258)187(301)245-75-26-36-138(245)176(290)212-90-146(259)217-121(61-64-147(260)261)162(276)233-133(86-149(264)265)166(280)216-101(13)183(297)242-72-27-37-139(242)177(291)215-100(12)156(270)219-123(62-65-148(262)263)164(278)234-134(87-150(266)267)172(286)227-125(76-94(3)4)165(279)214-99(11)155(269)218-117(32-22-68-208-188(199)200)159(273)229-128(80-105-42-52-111(252)53-43-105)168(282)230-129(81-106-44-54-112(253)55-45-106)169(283)237-136(91-247)154(198)268/h40-59,89,93-102,115-142,151-153,247-249,251-255H,16-39,60-88,90-92,192-194H2,1-15H3,(H2,195,256)(H2,196,257)(H2,197,258)(H2,198,268)(H,207,213)(H,212,290)(H,214,279)(H,215,291)(H,216,280)(H,217,259)(H,218,269)(H,219,270)(H,220,277)(H,221,281)(H,222,271)(H,223,292)(H,224,296)(H,225,289)(H,226,272)(H,227,286)(H,228,285)(H,229,273)(H,230,282)(H,231,284)(H,232,274)(H,233,276)(H,234,278)(H,235,294)(H,236,275)(H,237,283)(H,238,293)(H,239,288)(H,240,287)(H,241,295)(H,260,261)(H,262,263)(H,264,265)(H,266,267)(H4,199,200,208)(H4,201,202,209)(H4,203,204,210)(H4,205,206,211)/t97-,98-,99-,100-,101-,102+,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,151-,152-,153-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50437010
(CHEMBL2403024)Show SMILES CCN(CC)C(=O)C(C1CCN(CC1)c1ccc(NC(=O)c2c(C)noc2C)cc1F)c1ccccc1 Show InChI InChI=1S/C29H35FN4O3/c1-5-33(6-2)29(36)27(21-10-8-7-9-11-21)22-14-16-34(17-15-22)25-13-12-23(18-24(25)30)31-28(35)26-19(3)32-37-20(26)4/h7-13,18,22,27H,5-6,14-17H2,1-4H3,(H,31,35) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a |
Janssen Research& Development LLC
Curated by ChEMBL
| Assay Description
Antagonist activity at NPY-Y2 receptor in human KAN-TS cell membranes assessed as inhibition of PYY-stimulated [35S]GTPgammaS binding preincubated fo... |
Bioorg Med Chem Lett 23: 4141-4 (2013)
Article DOI: 10.1016/j.bmcl.2013.05.038
BindingDB Entry DOI: 10.7270/Q29C6ZV8 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003046
(CHEMBL386202 | Tyr-Pro-Ala-His-Tyr-Ile-Asn-Leu-Ile...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C78H120N22O19/c1-9-40(5)61(97-71(114)56(37-46-21-27-49(104)28-22-46)94-65(108)42(7)89-72(115)58-16-13-33-100(58)76(119)50(79)35-44-17-23-47(102)24-18-44)73(116)96-57(38-60(81)106)69(112)95-55(34-39(3)4)70(113)98-62(41(6)10-2)74(117)99-63(43(8)101)75(118)92-52(15-12-32-88-78(85)86)66(109)91-53(29-30-59(80)105)68(111)90-51(14-11-31-87-77(83)84)67(110)93-54(64(82)107)36-45-19-25-48(103)26-20-45/h17-28,39-43,50-58,61-63,101-104H,9-16,29-38,79H2,1-8H3,(H2,80,105)(H2,81,106)(H2,82,107)(H,89,115)(H,90,111)(H,91,109)(H,92,118)(H,93,110)(H,94,108)(H,95,112)(H,96,116)(H,97,114)(H,98,113)(H,99,117)(H4,83,84,87)(H4,85,86,88)/t40-,41-,42-,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,61-,62-,63-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003054
(CHEMBL406025 | c(30,34)-Ala-Arg-Tyr-Tyr-Ser-Ala-Le...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](NC(=O)[C@@H](NC1=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C111H169N35O28/c1-10-56(5)86(104(170)141-81(51-84(113)153)101(167)132-70-17-12-13-40-123-85(154)38-37-74(94(160)131-72(19-15-42-125-109(116)117)93(159)142-82(107(173)174)49-64-27-35-69(152)36-28-64)133-91(157)73(20-16-43-126-110(118)119)135-106(172)88(60(9)148)146-105(171)87(57(6)11-2)144-96(70)162)145-102(168)79(48-63-25-33-68(151)34-26-63)139-100(166)80(50-65-52-122-54-128-65)140-95(161)75(39-44-127-111(120)121)134-97(163)76(45-55(3)4)136-90(156)59(8)129-103(169)83(53-147)143-99(165)78(47-62-23-31-67(150)32-24-62)138-98(164)77(46-61-21-29-66(149)30-22-61)137-92(158)71(130-89(155)58(7)112)18-14-41-124-108(114)115/h21-36,52,54-60,70-83,86-88,147-152H,10-20,37-51,53,112H2,1-9H3,(H2,113,153)(H,122,128)(H,123,154)(H,129,169)(H,130,155)(H,131,160)(H,132,167)(H,133,157)(H,134,163)(H,135,172)(H,136,156)(H,137,158)(H,138,164)(H,139,166)(H,140,161)(H,141,170)(H,142,159)(H,143,165)(H,144,162)(H,145,168)(H,146,171)(H,173,174)(H4,114,115,124)(H4,116,117,125)(H4,118,119,126)(H4,120,121,127)/t56-,57-,58-,59-,60+,70+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,86-,87-,88+/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003047
(CHEMBL438211 | c(30,34)-Ala-Arg-Tyr-Tyr-Ser-Ala-Le...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]1(C)NC(=O)CC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](NC(=O)[C@@H](NC1=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C108H163N35O28/c1-11-53(5)82(99(166)136-77(48-80(110)150)98(165)143-108(10)103(171)141-83(54(6)12-2)100(167)140-84(57(9)145)101(168)130-69(18-15-40-122-106(115)116)87(154)128-70(35-36-81(151)142-108)90(157)127-68(17-14-39-121-105(113)114)89(156)137-78(102(169)170)46-61-25-33-66(149)34-26-61)139-96(163)75(45-60-23-31-65(148)32-24-60)134-95(162)76(47-62-49-119-51-124-62)135-91(158)71(37-41-123-107(117)118)129-92(159)72(42-52(3)4)131-86(153)56(8)125-97(164)79(50-144)138-94(161)74(44-59-21-29-64(147)30-22-59)133-93(160)73(43-58-19-27-63(146)28-20-58)132-88(155)67(126-85(152)55(7)109)16-13-38-120-104(111)112/h19-34,49,51-57,67-79,82-84,144-149H,11-18,35-48,50,109H2,1-10H3,(H2,110,150)(H,119,124)(H,125,164)(H,126,152)(H,127,157)(H,128,154)(H,129,159)(H,130,168)(H,131,153)(H,132,155)(H,133,160)(H,134,162)(H,135,158)(H,136,166)(H,137,156)(H,138,161)(H,139,163)(H,140,167)(H,141,171)(H,142,151)(H,143,165)(H,169,170)(H4,111,112,120)(H4,113,114,121)(H4,115,116,122)(H4,117,118,123)/t53-,54-,55-,56-,57+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,82-,83-,84+,108-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 590 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003045
(CHEMBL425080 | c(30,34)-Ala-Arg-Tyr-Tyr-Ser-Ala-Le...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](NC(=O)[C@@H](NC1=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C110H167N35O28/c1-10-55(5)85(103(169)140-80(50-83(112)152)100(166)131-72-16-12-39-122-84(153)37-36-73(93(159)130-70(18-14-41-124-108(115)116)92(158)141-81(106(172)173)48-63-26-34-68(151)35-27-63)132-90(156)71(19-15-42-125-109(117)118)134-105(171)87(59(9)147)145-104(170)86(56(6)11-2)143-95(72)161)144-101(167)78(47-62-24-32-67(150)33-25-62)138-99(165)79(49-64-51-121-53-127-64)139-94(160)74(38-43-126-110(119)120)133-96(162)75(44-54(3)4)135-89(155)58(8)128-102(168)82(52-146)142-98(164)77(46-61-22-30-66(149)31-23-61)137-97(163)76(45-60-20-28-65(148)29-21-60)136-91(157)69(129-88(154)57(7)111)17-13-40-123-107(113)114/h20-35,51,53-59,69-82,85-87,146-151H,10-19,36-50,52,111H2,1-9H3,(H2,112,152)(H,121,127)(H,122,153)(H,128,168)(H,129,154)(H,130,159)(H,131,166)(H,132,156)(H,133,162)(H,134,171)(H,135,155)(H,136,157)(H,137,163)(H,138,165)(H,139,160)(H,140,169)(H,141,158)(H,142,164)(H,143,161)(H,144,167)(H,145,170)(H,172,173)(H4,113,114,123)(H4,115,116,124)(H4,117,118,125)(H4,119,120,126)/t55-,56-,57-,58-,59+,69-,70-,71-,72+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,85-,86-,87+/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | 950 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003050
(CHEMBL407742 | c(1,30)Glu-Pro-Ala-Tyr-Ile-Asn-Dpr-...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@@]1(C)NC(=O)CC[C@@H](N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(N)=O)C(=O)N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C71H111N23O19/c1-8-34(3)53-64(109)88-48(33-51(74)99)62(107)93-71(7,92-52(100)27-24-42(72)67(112)94-30-12-15-49(94)63(108)82-36(5)57(102)87-47(61(106)89-53)32-39-18-22-41(97)23-19-39)68(113)91-54(35(4)9-2)65(110)90-55(37(6)95)66(111)85-44(14-11-29-81-70(78)79)58(103)84-45(25-26-50(73)98)60(105)83-43(13-10-28-80-69(76)77)59(104)86-46(56(75)101)31-38-16-20-40(96)21-17-38/h16-23,34-37,42-49,53-55,95-97H,8-15,24-33,72H2,1-7H3,(H2,73,98)(H2,74,99)(H2,75,101)(H,82,108)(H,83,105)(H,84,103)(H,85,111)(H,86,104)(H,87,102)(H,88,109)(H,89,106)(H,90,110)(H,91,113)(H,92,100)(H,93,107)(H4,76,77,80)(H4,78,79,81)/t34-,35-,36-,37+,42+,43-,44-,45-,46-,47+,48+,49+,53-,54-,55-,71-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50003052
(CHEMBL413658 | c(33,36)-Ala-Arg-Tyr-Tyr-Ser-Ala-Le...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]1CCCCNC(=O)CC[C@@H](NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC1=O)C(N)=O)C(=O)N[C@@H](CC(N)=O)C(C)=O |wU:112.115,96.99,4.4,20.28,71.83,59.70,159.163,129.157,30.38,144.148,113.118,48.50,105.109,wD:53.57,104.107,8.17,40.46,119.122,83.94,133.137,2.2,(16.33,-35.94,;16.45,-37.49,;17.83,-38.16,;18.23,-36.64,;17.95,-39.68,;16.67,-40.54,;15.29,-39.88,;15.17,-38.35,;14.03,-40.75,;14.13,-42.28,;15.51,-42.96,;16.79,-42.09,;18.17,-42.74,;18.29,-44.28,;19.67,-44.95,;17.01,-45.15,;15.63,-44.47,;12.62,-40.08,;11.36,-40.96,;11.48,-42.49,;9.98,-40.28,;9.86,-38.75,;11.12,-37.89,;12.57,-38.39,;13.51,-37.18,;12.66,-35.91,;11.17,-36.34,;8.71,-41.15,;7.31,-40.48,;6.05,-41.34,;7.19,-38.95,;8.5,-38.07,;8.48,-36.53,;9.83,-35.75,;9.83,-34.98,;8.5,-34.21,;11.16,-34.23,;5.82,-38.28,;5.71,-36.75,;6.98,-35.89,;4.33,-36.08,;3.06,-36.95,;3.17,-38.49,;1.9,-39.35,;4.55,-39.15,;4.21,-34.54,;2.83,-33.89,;1.56,-34.76,;2.71,-32.34,;3.97,-31.48,;1.32,-31.69,;1.21,-30.15,;2.48,-29.29,;-.17,-29.49,;-1.45,-30.35,;-1.33,-31.88,;-.29,-27.95,;-1.68,-27.27,;-2.94,-28.15,;-1.8,-25.76,;-.52,-24.89,;.86,-25.55,;2.14,-24.7,;3.5,-25.35,;3.62,-26.87,;5.02,-27.55,;2.36,-27.76,;.98,-27.09,;-3.18,-25.08,;-3.29,-23.55,;-4.67,-22.88,;-2.01,-22.69,;-.46,-22.69,;2.14,-22.66,;2.94,-23.98,;4.48,-23.93,;5.21,-22.57,;6.75,-22.53,;4.39,-21.26,;2.85,-21.31,;-2.13,-21.15,;-.86,-20.29,;.52,-20.96,;-.98,-18.74,;-2.36,-18.09,;-3.63,-18.95,;-5.03,-18.28,;-6.29,-19.14,;-7.68,-18.49,;-7.79,-16.97,;-8.95,-19.35,;.28,-17.9,;.16,-16.36,;-1.22,-15.69,;1.45,-15.5,;2.83,-16.17,;1.99,-14.1,;1.13,-12.81,;1.87,-11.42,;1.03,-10.2,;3.44,-11.28,;3.56,-14.04,;4.42,-15.31,;4.34,-12.76,;5.84,-12.78,;6.66,-14.02,;8.25,-13.84,;5.95,-15.38,;6.8,-16.67,;6.48,-11.34,;5.63,-10.06,;7.98,-11.13,;8.56,-9.73,;7.68,-8.45,;6.11,-8.59,;8.41,-7.05,;10.12,-9.64,;10.99,-10.92,;11.29,-8.65,;12.74,-9.19,;12.47,-10.71,;12.74,-12.22,;13.51,-13.55,;14.7,-14.56,;16.15,-15.08,;17.69,-15.08,;17.95,-16.59,;19.13,-14.56,;20.32,-13.55,;21.09,-12.22,;21.36,-10.71,;21.09,-9.19,;22.54,-8.65,;20.32,-7.87,;21.5,-6.87,;22.94,-7.39,;24.14,-6.4,;25.58,-6.93,;25.85,-8.45,;27.3,-8.97,;24.65,-9.44,;19.13,-6.87,;17.69,-6.34,;17.95,-4.83,;16.15,-6.34,;15.89,-4.83,;17.06,-3.85,;16.79,-2.32,;15.33,-1.77,;17.97,-1.32,;14.7,-6.87,;13.51,-7.87,;12.33,-6.87,;22.54,-12.76,;23.72,-11.77,;22.81,-14.28,;19.32,-40.36,;19.44,-41.9,;20.59,-39.49,;20.47,-37.95,;19.09,-37.29,;18.98,-35.75,;20.25,-34.89,;17.6,-35.09,;21.75,-37.09,;22.84,-35.98,;23.13,-37.76,)| Show InChI InChI=1S/C107H167N33O27/c1-13-55(7)84(101(164)129-73(58(10)142)49-82(109)148)137-98(161)77(47-62-26-32-66(146)33-27-62)133-97(160)78(48-63-50-117-52-122-63)134-93(156)72(38-42-121-106(115)116)127-94(157)74(43-53(3)4)130-88(151)57(9)123-99(162)79(51-141)135-96(159)76(46-61-24-30-65(145)31-25-61)132-95(158)75(45-60-22-28-64(144)29-23-60)131-91(154)70(21-18-41-120-105(113)114)136-107(167)140(12)80(44-54(5)6)100(163)138-85(56(8)14-2)102(165)139-86(59(11)143)103(166)128-68-19-15-16-39-118-83(149)37-35-67(87(110)150)124-89(152)69(20-17-40-119-104(111)112)125-92(155)71(126-90(68)153)34-36-81(108)147/h22-33,50,52-57,59,67-80,84-86,141,143-146H,13-21,34-49,51H2,1-12H3,(H2,108,147)(H2,109,148)(H2,110,150)(H,117,122)(H,118,149)(H,123,162)(H,124,152)(H,125,155)(H,126,153)(H,127,157)(H,128,166)(H,129,164)(H,130,151)(H,131,154)(H,132,158)(H,133,160)(H,134,156)(H,135,159)(H,136,167)(H,137,161)(H,138,163)(H,139,165)(H4,111,112,119)(H4,113,114,120)(H4,115,116,121)/t55-,56-,57-,59+,67+,68-,69+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,84-,85-,86-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a |
Salk Institute
Curated by ChEMBL
| Assay Description
Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells |
J Med Chem 35: 3653-9 (1992)
BindingDB Entry DOI: 10.7270/Q2QZ2BK9 |
More data for this
Ligand-Target Pair | |
Search and Browse
